Global Nanomedicine Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Jul-2021
No. of pages: 105
Inquire Before Buying

Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.

As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.

Market Analysis and Insights: Global Nanomedicine Market

The global Nanomedicine market size is projected to reach US$ 246.8 million by 2027, from US$ 155.5 million in 2020, at a CAGR of 6.4% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanomedicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanomedicine market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanomedicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanomedicine market.

Global Nanomedicine Scope and Market Size

Nanomedicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanomedicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Quantum dots

- Nanoparticles

- Nanoshells

- Nanotubes

- Nanodevices

Segment by Application

- oncology

- Infectious diseases

- Cardiology

- Orthopedics

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Combimatrix

- Ablynx

- Abraxis Bioscience

- Celgene

- Mallinckrodt

- Arrowhead Research

- GE Healthcare

- Merck

- Pfizer

- Nanosphere

- Epeius Biotechnologies

- Cytimmune Sciences

- Nanospectra Biosciences

Global Nanomedicine Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Quantum dots
1.2.3 Nanoparticles
1.2.4 Nanoshells
1.2.5 Nanotubes
1.2.6 Nanodevices
1.3 Market by Application
1.3.1 Global Nanomedicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 oncology
1.3.3 Infectious diseases
1.3.4 Cardiology
1.3.5 Orthopedics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicine Market Perspective (2016-2027)
2.2 Nanomedicine Growth Trends by Regions
2.2.1 Nanomedicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nanomedicine Historic Market Share by Regions (2016-2021)
2.2.3 Nanomedicine Forecasted Market Size by Regions (2022-2027)
2.3 Nanomedicine Industry Dynamic
2.3.1 Nanomedicine Market Trends
2.3.2 Nanomedicine Market Drivers
2.3.3 Nanomedicine Market Challenges
2.3.4 Nanomedicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicine Players by Revenue
3.1.1 Global Top Nanomedicine Players by Revenue (2016-2021)
3.1.2 Global Nanomedicine Revenue Market Share by Players (2016-2021)
3.2 Global Nanomedicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nanomedicine Revenue
3.4 Global Nanomedicine Market Concentration Ratio
3.4.1 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine Revenue in 2020
3.5 Nanomedicine Key Players Head office and Area Served
3.6 Key Players Nanomedicine Product Solution and Service
3.7 Date of Enter into Nanomedicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicine Breakdown Data by Type
4.1 Global Nanomedicine Historic Market Size by Type (2016-2021)
4.2 Global Nanomedicine Forecasted Market Size by Type (2022-2027)
5 Nanomedicine Breakdown Data by Application
5.1 Global Nanomedicine Historic Market Size by Application (2016-2021)
5.2 Global Nanomedicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nanomedicine Market Size (2016-2027)
6.2 North America Nanomedicine Market Size by Type
6.2.1 North America Nanomedicine Market Size by Type (2016-2021)
6.2.2 North America Nanomedicine Market Size by Type (2022-2027)
6.2.3 North America Nanomedicine Market Size by Type (2016-2027)
6.3 North America Nanomedicine Market Size by Application
6.3.1 North America Nanomedicine Market Size by Application (2016-2021)
6.3.2 North America Nanomedicine Market Size by Application (2022-2027)
6.3.3 North America Nanomedicine Market Size by Application (2016-2027)
6.4 North America Nanomedicine Market Size by Country
6.4.1 North America Nanomedicine Market Size by Country (2016-2021)
6.4.2 North America Nanomedicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nanomedicine Market Size (2016-2027)
7.2 Europe Nanomedicine Market Size by Type
7.2.1 Europe Nanomedicine Market Size by Type (2016-2021)
7.2.2 Europe Nanomedicine Market Size by Type (2022-2027)
7.2.3 Europe Nanomedicine Market Size by Type (2016-2027)
7.3 Europe Nanomedicine Market Size by Application
7.3.1 Europe Nanomedicine Market Size by Application (2016-2021)
7.3.2 Europe Nanomedicine Market Size by Application (2022-2027)
7.3.3 Europe Nanomedicine Market Size by Application (2016-2027)
7.4 Europe Nanomedicine Market Size by Country
7.4.1 Europe Nanomedicine Market Size by Country (2016-2021)
7.4.2 Europe Nanomedicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicine Market Size (2016-2027)
8.2 Asia-Pacific Nanomedicine Market Size by Type
8.2.1 Asia-Pacific Nanomedicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nanomedicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nanomedicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Nanomedicine Market Size by Application
8.3.1 Asia-Pacific Nanomedicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nanomedicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nanomedicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Nanomedicine Market Size by Region
8.4.1 Asia-Pacific Nanomedicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nanomedicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nanomedicine Market Size (2016-2027)
9.2 Latin America Nanomedicine Market Size by Type
9.2.1 Latin America Nanomedicine Market Size by Type (2016-2021)
9.2.2 Latin America Nanomedicine Market Size by Type (2022-2027)
9.2.3 Latin America Nanomedicine Market Size by Type (2016-2027)
9.3 Latin America Nanomedicine Market Size by Application
9.3.1 Latin America Nanomedicine Market Size by Application (2016-2021)
9.3.2 Latin America Nanomedicine Market Size by Application (2022-2027)
9.3.3 Latin America Nanomedicine Market Size by Application (2016-2027)
9.4 Latin America Nanomedicine Market Size by Country
9.4.1 Latin America Nanomedicine Market Size by Country (2016-2021)
9.4.2 Latin America Nanomedicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicine Market Size (2016-2027)
10.2 Middle East & Africa Nanomedicine Market Size by Type
10.2.1 Middle East & Africa Nanomedicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nanomedicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nanomedicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Nanomedicine Market Size by Application
10.3.1 Middle East & Africa Nanomedicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nanomedicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nanomedicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Nanomedicine Market Size by Country
10.4.1 Middle East & Africa Nanomedicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nanomedicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Combimatrix
11.1.1 Combimatrix Company Details
11.1.2 Combimatrix Business Overview
11.1.3 Combimatrix Nanomedicine Introduction
11.1.4 Combimatrix Revenue in Nanomedicine Business (2016-2021)
11.1.5 Combimatrix Recent Development
11.2 Ablynx
11.2.1 Ablynx Company Details
11.2.2 Ablynx Business Overview
11.2.3 Ablynx Nanomedicine Introduction
11.2.4 Ablynx Revenue in Nanomedicine Business (2016-2021)
11.2.5 Ablynx Recent Development
11.3 Abraxis Bioscience
11.3.1 Abraxis Bioscience Company Details
11.3.2 Abraxis Bioscience Business Overview
11.3.3 Abraxis Bioscience Nanomedicine Introduction
11.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2016-2021)
11.3.5 Abraxis Bioscience Recent Development
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Nanomedicine Introduction
11.4.4 Celgene Revenue in Nanomedicine Business (2016-2021)
11.4.5 Celgene Recent Development
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Details
11.5.2 Mallinckrodt Business Overview
11.5.3 Mallinckrodt Nanomedicine Introduction
11.5.4 Mallinckrodt Revenue in Nanomedicine Business (2016-2021)
11.5.5 Mallinckrodt Recent Development
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Details
11.6.2 Arrowhead Research Business Overview
11.6.3 Arrowhead Research Nanomedicine Introduction
11.6.4 Arrowhead Research Revenue in Nanomedicine Business (2016-2021)
11.6.5 Arrowhead Research Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Nanomedicine Introduction
11.7.4 GE Healthcare Revenue in Nanomedicine Business (2016-2021)
11.7.5 GE Healthcare Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Nanomedicine Introduction
11.8.4 Merck Revenue in Nanomedicine Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nanomedicine Introduction
11.9.4 Pfizer Revenue in Nanomedicine Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Nanosphere
11.10.1 Nanosphere Company Details
11.10.2 Nanosphere Business Overview
11.10.3 Nanosphere Nanomedicine Introduction
11.10.4 Nanosphere Revenue in Nanomedicine Business (2016-2021)
11.10.5 Nanosphere Recent Development
11.11 Epeius Biotechnologies
11.11.1 Epeius Biotechnologies Company Details
11.11.2 Epeius Biotechnologies Business Overview
11.11.3 Epeius Biotechnologies Nanomedicine Introduction
11.11.4 Epeius Biotechnologies Revenue in Nanomedicine Business (2016-2021)
11.11.5 Epeius Biotechnologies Recent Development
11.12 Cytimmune Sciences
11.12.1 Cytimmune Sciences Company Details
11.12.2 Cytimmune Sciences Business Overview
11.12.3 Cytimmune Sciences Nanomedicine Introduction
11.12.4 Cytimmune Sciences Revenue in Nanomedicine Business (2016-2021)
11.12.5 Cytimmune Sciences Recent Development
11.13 Nanospectra Biosciences
11.13.1 Nanospectra Biosciences Company Details
11.13.2 Nanospectra Biosciences Business Overview
11.13.3 Nanospectra Biosciences Nanomedicine Introduction
11.13.4 Nanospectra Biosciences Revenue in Nanomedicine Business (2016-2021)
11.13.5 Nanospectra Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Nanomedicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Quantum dots
Table 3. Key Players of Nanoparticles
Table 4. Key Players of Nanoshells
Table 5. Key Players of Nanotubes
Table 6. Key Players of Nanodevices
Table 7. Global Nanomedicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nanomedicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nanomedicine Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Nanomedicine Market Share by Regions (2016-2021)
Table 11. Global Nanomedicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Nanomedicine Market Share by Regions (2022-2027)
Table 13. Nanomedicine Market Trends
Table 14. Nanomedicine Market Drivers
Table 15. Nanomedicine Market Challenges
Table 16. Nanomedicine Market Restraints
Table 17. Global Nanomedicine Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Nanomedicine Market Share by Players (2016-2021)
Table 19. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicine as of 2020)
Table 20. Ranking of Global Top Nanomedicine Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Nanomedicine Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nanomedicine Product Solution and Service
Table 24. Date of Enter into Nanomedicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Nanomedicine Revenue Market Share by Type (2016-2021)
Table 28. Global Nanomedicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Nanomedicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Nanomedicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Nanomedicine Revenue Market Share by Application (2016-2021)
Table 32. Global Nanomedicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Nanomedicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Nanomedicine Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Nanomedicine Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Nanomedicine Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Nanomedicine Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Nanomedicine Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Nanomedicine Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Nanomedicine Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Nanomedicine Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Nanomedicine Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Nanomedicine Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nanomedicine Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nanomedicine Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Nanomedicine Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Nanomedicine Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Nanomedicine Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Nanomedicine Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Nanomedicine Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Nanomedicine Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Nanomedicine Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Nanomedicine Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nanomedicine Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nanomedicine Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nanomedicine Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Nanomedicine Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Nanomedicine Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Nanomedicine Market Size by Country (2022-2027) & (US$ Million)
Table 64. Combimatrix Company Details
Table 65. Combimatrix Business Overview
Table 66. Combimatrix Nanomedicine Product
Table 67. Combimatrix Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 68. Combimatrix Recent Development
Table 69. Ablynx Company Details
Table 70. Ablynx Business Overview
Table 71. Ablynx Nanomedicine Product
Table 72. Ablynx Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 73. Ablynx Recent Development
Table 74. Abraxis Bioscience Company Details
Table 75. Abraxis Bioscience Business Overview
Table 76. Abraxis Bioscience Nanomedicine Product
Table 77. Abraxis Bioscience Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 78. Abraxis Bioscience Recent Development
Table 79. Celgene Company Details
Table 80. Celgene Business Overview
Table 81. Celgene Nanomedicine Product
Table 82. Celgene Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 83. Celgene Recent Development
Table 84. Mallinckrodt Company Details
Table 85. Mallinckrodt Business Overview
Table 86. Mallinckrodt Nanomedicine Product
Table 87. Mallinckrodt Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 88. Mallinckrodt Recent Development
Table 89. Arrowhead Research Company Details
Table 90. Arrowhead Research Business Overview
Table 91. Arrowhead Research Nanomedicine Product
Table 92. Arrowhead Research Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 93. Arrowhead Research Recent Development
Table 94. GE Healthcare Company Details
Table 95. GE Healthcare Business Overview
Table 96. GE Healthcare Nanomedicine Product
Table 97. GE Healthcare Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 98. GE Healthcare Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Nanomedicine Product
Table 106. Pfizer Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 107. Pfizer Recent Development
Table 108. Nanosphere Company Details
Table 109. Nanosphere Business Overview
Table 110. Nanosphere Nanomedicine Product
Table 111. Nanosphere Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 112. Nanosphere Recent Development
Table 113. Epeius Biotechnologies Company Details
Table 114. Epeius Biotechnologies Business Overview
Table 115. Epeius Biotechnologies Nanomedicine Product
Table 116. Epeius Biotechnologies Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 117. Epeius Biotechnologies Recent Development
Table 118. Cytimmune Sciences Company Details
Table 119. Cytimmune Sciences Business Overview
Table 120. Cytimmune Sciences Nanomedicine Product
Table 121. Cytimmune Sciences Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 122. Cytimmune Sciences Recent Development
Table 123. Nanospectra Biosciences Company Details
Table 124. Nanospectra Biosciences Business Overview
Table 125. Nanospectra Biosciences Nanomedicine Product
Table 126. Nanospectra Biosciences Revenue in Nanomedicine Business (2016-2021) & (US$ Million)
Table 127. Nanospectra Biosciences Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomedicine Market Share by Type: 2020 VS 2027
Figure 2. Quantum dots Features
Figure 3. Nanoparticles Features
Figure 4. Nanoshells Features
Figure 5. Nanotubes Features
Figure 6. Nanodevices Features
Figure 7. Global Nanomedicine Market Share by Application: 2020 VS 2027
Figure 8. oncology Case Studies
Figure 9. Infectious diseases Case Studies
Figure 10. Cardiology Case Studies
Figure 11. Orthopedics Case Studies
Figure 12. Others Case Studies
Figure 13. Nanomedicine Report Years Considered
Figure 14. Global Nanomedicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Nanomedicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Nanomedicine Market Share by Regions: 2020 VS 2027
Figure 17. Global Nanomedicine Market Share by Regions (2022-2027)
Figure 18. Global Nanomedicine Market Share by Players in 2020
Figure 19. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicine as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Nanomedicine Revenue in 2020
Figure 21. Global Nanomedicine Revenue Market Share by Type (2016-2021)
Figure 22. Global Nanomedicine Revenue Market Share by Type (2022-2027)
Figure 23. North America Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Nanomedicine Market Share by Type (2016-2027)
Figure 25. North America Nanomedicine Market Share by Application (2016-2027)
Figure 26. North America Nanomedicine Market Share by Country (2016-2027)
Figure 27. United States Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Nanomedicine Market Share by Type (2016-2027)
Figure 31. Europe Nanomedicine Market Share by Application (2016-2027)
Figure 32. Europe Nanomedicine Market Share by Country (2016-2027)
Figure 33. Germany Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Nanomedicine Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Nanomedicine Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Nanomedicine Market Share by Region (2016-2027)
Figure 43. China Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Nanomedicine Market Share by Type (2016-2027)
Figure 51. Latin America Nanomedicine Market Share by Application (2016-2027)
Figure 52. Latin America Nanomedicine Market Share by Country (2016-2027)
Figure 53. Mexico Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Nanomedicine Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Nanomedicine Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Nanomedicine Market Share by Country (2016-2027)
Figure 59. Turkey Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Nanomedicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Combimatrix Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 63. Ablynx Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 64. Abraxis Bioscience Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 65. Celgene Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 66. Mallinckrodt Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 67. Arrowhead Research Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 68. GE Healthcare Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 71. Nanosphere Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 72. Epeius Biotechnologies Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 73. Cytimmune Sciences Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 74. Nanospectra Biosciences Revenue Growth Rate in Nanomedicine Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Nanopharmaceuticals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 153
    According to our LPI (LP Information) latest study, the global Nanopharmaceuticals market size was valued at US$ 30290 million in 2023. With growing demand in downstream market, the Nanopharmaceuticals is forecast to a readjusted size of US$ 73420 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Nanopharmaceuticals market. Nanopharmaceuticals are expected to show stable growth in the future market. However, produ......
  • Global Nanomedicine Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 87
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nanomedicine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Combimatrix - Ablynx - Abraxis Bioscience - Celgene - Mallinckrodt - Arrowhead Research - GE Healthcare - Merck - Pfizer - Na......
  • Global Nanomedicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global Nanomedicine market: According to our latest research, the global Nanomedicine market looks promising in the next 5 years. As of 2022, the global Nanomedicine market was estimated at USD 181.26 million, and it's anticipated to reach USD 263.67 million in 2028, with a CAGR of 6.45% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nanomedicine market, with......
  • Nanomaterials in Personalized Medicine: Global Markets
    Published: 20-Oct-2023        Price: US 5500 Onwards        Pages: 226
    Report Scope: The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competiti......
  • 2023-2031 Report on Global Nanopharmaceuticals Market by Player, Region, Type, Application and Sales Channel
    Published: 09-Oct-2023        Price: US 2500 Onwards        Pages: 122
    This report studies the Nanopharmaceuticals market, covering market size for segment by type (Liposomes, Polymeric Micelles, etc.), by application (Cancer and Tumor, Autoimmune Disorders, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Na......
  • Global Cancer Nanomedicine Market Insights, Forecast to 2029
    Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 111
    Nanomedicine is a branch of nanotechnology that uses nanoparticles to diagnose, treat, monitor, and control biological systems. By manipulating materials at the nanoscale, it improves medicine delivery. As a result, nanomedicine has helped treat a wide range of diseases. Nanomedicine is still in its infancy, with numerous products in the works. Nanobiotix has identified 230 nanomedicine products that are either patented or in the early stages of development. 49 of the 230 products are on the mar......
  • Asia-Pacific Nanotechnology In Energy Applications Market Forecast 2023-2032
    Published: 18-Aug-2023        Price: US 1600 Onwards        Pages: 175
    KEY FINDINGS The Asia-Pacific nanotechnology in energy applications market is projected to grow with a CAGR of 13.24% during the forecasting years of 2023-2032. The regional market's growth is ascribed to the gradual improvement of the nanotechnology profile in scientific research, supportive government policies and regulations aimed at promoting renewable energy as well as reducing carbon footprint, and rising concerns associated with greenhouse emissions and safety. ......
  • Europe Nanotechnology In Energy Applications Market Forecast 2023-2032
    Published: 18-Aug-2023        Price: US 1600 Onwards        Pages: 165
    KEY FINDINGS The Europe nanotechnology in energy applications market is set to grow with a CAGR of 12.89% over the forecast period of 2023-2032. The regional market's growth is accredited to the European Union's (EU) significant role in promoting nanotechnology in the energy sector as well as the efforts directed toward the transition to a low-carbon economy and minimizing greenhouse gas emissions. MARKET INSIGHTS The United Kingdom, Italy, Spain, Pol......
  • North America Nanotechnology In Energy Applications Market Forecast 2023-2032
    Published: 18-Aug-2023        Price: US 1600 Onwards        Pages: 168
    KEY FINDINGS The North America nanotechnology in energy applications market is estimated to record a CAGR of 13.01% over the forecast period of 2023-2032. The market growth of the region is augmented by increasing customer demand for high-performance, longer-lasting products, the introduction of new standards and technologies, as well as evolving regulatory requirements. MARKET INSIGHTS Canada and the United States are evaluated for the North America ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs